Publications by authors named "J F MacMaster"

Claim this Profile
A
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
Fergus R Byrne, Aaron Winters, David Brankow, Sylvia Hu, Todd Juan, John Macmaster

Autoimmunity· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.
Francis Beaulieu, Carl Ouellet, Edward H Ruediger, Makonen Belema, Yuping Qiu, John F MacMaster

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Mark A Pattoli, John F MacMaster, Kurt R Gregor, James R Burke

J Pharmacol Exp Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice.
J F MacMaster, D M Dambach, D B Lee, K K Berry, Y Qiu

Inflamm Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductively activated disulfide prodrugs of paclitaxel.
Vivekananda M Vrudhula, John F MacMaster, Zhengong Li, David E Kerr, Peter D Senter

Bioorg Med Chem Lett· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis